OptiNose Inc. (NASDAQ: OPTN) Stock Information | RedChip

OptiNose Inc. (NASDAQ: OPTN)


$1.16
-0.1100 ( -8.66% ) 1.3M

OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

Market Data


Open


$1.16

Previous close


$1.27

Volume


1.3M

Market cap


$130.00M

Day range


$1.14 - $1.26

52 week range


$0.80 - $2.10

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Feb 23, 2024
4 Insider transactions 1 Feb 01, 2024
8-k 8K-related 14 Dec 21, 2023
4 Insider transactions 1 Dec 20, 2023
4 Insider transactions 1 Dec 20, 2023
8-k 8K-related 15 Dec 06, 2023
8-k 8K-related 38 Nov 09, 2023
10-q Quarterly Reports 65 Nov 09, 2023
4 Insider transactions 1 Sep 19, 2023
4 Insider transactions 1 Sep 19, 2023

Latest News